Jun Zhang
75Patents
10h-index
178Co-inventors
81Inventor score
Filing activity: Feb 13, 1998 → Jan 16, 2025
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7597886B2 | Tumor necrosis factor-gamma | Emerging Cross-Sectional Technologies | 37 | Expired |
| US8603467B2 | Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof | Physics | 30 | Active |
| US6811773B1 | Human monocyte colony inhibitory factor (M-CIF) polypeptides | Physics | 29 | Expired |
| US6077692A | Keratinocyte growth factor-2 | Chemistry; Metallurgy | 23 | Expired |
| US7820798B2 | Tumor necrosis factor-gamma | Emerging Cross-Sectional Technologies | 21 | Active |
| US9683998B2 | Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof | Chemistry; Metallurgy | 21 | Active |
| US6824767B2 | Tumor necrosis factor-gamma | Emerging Cross-Sectional Technologies | 15 | Expired |
| US6693077B1 | Keratinocyte growth factor-2 | Chemistry; Metallurgy | 13 | Expired |
| US8093363B2 | Tumor necrosis factor-gamma | Emerging Cross-Sectional Technologies | 12 | Active |
| US7851596B2 | Myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptides | Physics | 10 | Active |
| US10047111B2 | RNA interference agents for GST-PI gene modulation | Chemistry; Metallurgy | 9 | Active |
| US6495520B2 | Apoptosis Inducing Molecule II and methods of use | Chemistry; Metallurgy | 7 | Expired |
| US9308267B2 | Lipids for therapeutic agent delivery formulations | Emerging Cross-Sectional Technologies | 6 | Active |
| US9751914B2 | Polypeptides and antibodies for treating HBV infection and related diseases | Physics | 5 | Active |
| US10047110B2 | RNA agents for GST-Pi gene modulation | Chemistry; Metallurgy | 5 | Active |
| US7232667B2 | Keratinocyte growth factor-2 polynucleotides | Chemistry; Metallurgy | 4 | Expired |
| US10358497B2 | Methods of treating cardiovascular disease with an ASGR inhibitor | Chemistry; Metallurgy | 4 | Active |
| US10441659B2 | Lipids for therapeutic agent delivery formulations | Emerging Cross-Sectional Technologies | 3 | Active |
| US7786264B2 | Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof | Chemistry; Metallurgy | 2 | Expired |
| US10246494B2 | Polypeptides and antibodies for treating HBV infection and related diseases | Physics | 1 | Active |
| US6916786B2 | Keratinocyte growth factor-2 | Chemistry; Metallurgy | 1 | Expired |
| US6903072B2 | Keratinocyte growth factor-2 | Chemistry; Metallurgy | 1 | Expired |
| US7615228B2 | Polypeptide fragments of hepatitis E virus, the vaccine comprising said fragments and the diagnostic kits | Chemistry; Metallurgy | 1 | Expired |
| US7364865B2 | Antibodies to myeloid progenitor inhibitory factor-1 (MPIF-1) | Physics | 1 | Expired |
| US7041460B2 | Antibodies to monocyte-colony inhibitory factor (M-CIF) | Physics | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.